Author

Hilal H. Al-Shekaili

Sultan Qaboos UniversityORCID 0000-0002-9918-1942Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Blair R. LeavittiD· 2 shared Clara van KarnebeekiD· 2 shared Udo F. H. EngelkeiD· 2 shared Alejandro GarantoiD· 1 shared Arno van Rooij· 1 shared Astrid R. Oudakker· 1 shared Dirk J. LefeberiD· 1 shared Eduard A. StruysiD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Blair R. LeavittORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyMolecular Therapy — Nucleic AcidsPeer-reviewedOct 1, 2025

Targeting AASS improves neurotoxicity and mitochondrial function in astrocyte models for pyridoxine dependent epilepsy

Imke M. E. Schuurmans, Udo F. H. Engelke, Muna Abedrabbo…·Alejandro Garanto

This study shows that targeting AASS in astrocytes reduces neurotoxicity and improves mitochondrial function in a model of pyridoxine-dependent epilepsy.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineJournal of Clinical InvestigationPeer-reviewedJun 17, 2021

Identification of novel biomarkers for pyridoxine-dependent epilepsy using untargeted metabolomics and infrared ion spectroscopy - biochemical insights and clinical implications

Udo F. H. Engelke, Rianne E. van Outersterp, Jona Merx…·Karlien L. M. Coene

The paper identifies novel biomarkers for pyridoxine-dependent epilepsy using metabolomics and infrared ion spectroscopy, showing their potential for newborn screening and clinical implications.

67 citationstop 1%

humanmouse

𝕏 PostBluesky